Saw Palmetto
Saw Palmetto is the dried fruit of Serenoa repens, a small palm native to the south-eastern United States. It is sold in the UK as a food supplement — typically as a fat-soluble extract concentrated for fatty acids and sterols. There are no authorised UK health claims for Saw Palmetto. NHS and NICE pathways for benign prostatic hyperplasia (BPH) and male pattern hair loss do not list Saw Palmetto as a treatment.
Camden Medicals editorial · Last reviewed 12 June 2026 · Next review December 2026
- Cross-checked against
- NHS
- NICE
- BNF
- EFSA
- FSA
Camden's editorial team independently graded each health claim below on the strength of the published evidence — see the grade beside every condition.
- Class
- Botanical
- Typical daily dose
- Trials of standardised lipidosterolic extracts have most commonly used 320 mg/day, taken as a single dose or split as 160 mg twice daily. Ground-berry preparations have not been studied at directly comparable doses.
- Top use evidence
- Mixed
On this page
What it is
Saw Palmetto (Serenoa repens) is a small fan palm that produces dark berries used in commercial supplements. The fat-soluble fraction of the dried berry contains free fatty acids (lauric, oleic, palmitic, myristic), phytosterols (β-sitosterol, campesterol, stigmasterol), and small amounts of flavonoids and polysaccharides. The lipidosterolic extract — typically prepared by supercritical CO₂ extraction or hexane/ethanol extraction — is the form most investigated in clinical trials.
The relevant question for any saw palmetto supplement is which extract you are buying. A CO₂-extracted oil standardised to 85–95% total fatty acids sits closest to the materials used in published trials (Permixon® / Prostaserene® / SPET-085 are research-grade preparations of this kind). Ground berry powder, encapsulated at the same milligram label, contains a different and largely unstudied composition, with much lower lipid content by mass.
At a glance
- Dried-fruit extract of the Serenoa repens palm; sold in the UK as a food supplement.
- No UK-authorised health claims; EFSA evaluation on hold for botanicals.
- Quality varies enormously: a CO₂-extracted oil standardised to 85–95% fatty acids is what the better trials studied; ground-berry powder at the same milligram label tells you nothing about active content.
- Not a treatment for benign prostatic hyperplasia (BPH), prostate cancer, or male pattern hair loss. UK NHS pathways apply.
- Talk to your pharmacist or GP if urinary symptoms are new, getting worse, painful, or paired with blood — these need assessment, not a supplement.
What people use it for
Adults curious about a long-marketed botanical for urinary symptoms
Saw palmetto has a long history of consumer use; the contemporary clinical evidence is mixed and the highest-quality independent trials are negative. Talk to your pharmacist or GP about urinary symptoms before relying on a supplement.
Popular, not provenMixedMen with persistent or worsening lower urinary tract symptoms (weak stream, hesitancy, frequency, nocturia)
See your GP. NHS and NICE pathways for benign prostatic hyperplasia (BPH) include alpha blockers, 5α-reductase inhibitors, and surgical options where indicated. Saw palmetto is not part of these pathways. [9,1]
Popular, not provenInsufficientPeople exploring supplements for male pattern hair loss
Evidence is limited and lower-quality than for finasteride or topical minoxidil. UK NHS pathways and licensed treatments for androgenetic alopecia exist; talk to your pharmacist. [3]
Some evidenceLimitedPeople with red-flag urinary symptoms (blood in urine, pain, fever, sudden retention)
These need urgent assessment, not a supplement. Contact 111 / your GP. [10]
Popular, not provenInsufficient
How it works
In laboratory studies, saw palmetto lipid extracts have been reported to inhibit 5α-reductase isoenzymes (the enzymes that convert testosterone to dihydrotestosterone), to interact with androgen receptors, and to modulate inflammatory mediators in prostatic tissue. The clinical translation of these mechanisms in humans is uncertain. Published clinical effect sizes on lower urinary tract symptoms have been small and heterogeneous, and the highest-quality independent trials (notably the NIH-funded STEP and CAMUS trials) did not find clinically meaningful benefit over placebo at the doses tested.
Common myths
Myth"Saw palmetto is a "natural finasteride" with the same effect and no side effects"
RealitySaw palmetto and finasteride both have laboratory evidence of 5α-reductase inhibition, but at very different magnitudes and with different clinical readouts. Finasteride at 5 mg/day produces measurable, dose-dependent PSA and prostate-volume reduction. Saw palmetto in the largest independent trials did not. Naturalness is also not a clinical reasoning standard: case reports of liver injury and pre-surgical bleeding exist for saw palmetto, while finasteride has its own well-characterised side-effect profile. They are not interchangeable, and neither claim "no side effects" is accurate. [5]
Myth"A 320 mg saw palmetto capsule is a 320 mg saw palmetto capsule"
RealityTwo products labelled "320 mg saw palmetto" can deliver completely different bioactive content depending on whether the contents are ground dried berry powder, an ethanol extract, a hexane extract, or a CO₂-extracted lipidosterolic oil. The clinical literature is almost exclusively on lipidosterolic extracts standardised to fatty acid content. Without that standardisation on the label, the milligram figure tells you nothing comparable.
Myth"Saw palmetto cures prostate cancer"
RealityIt does not. Saw palmetto is not a treatment for prostate cancer and is not part of NHS or NICE prevention or treatment pathways. Any marketing implying cancer prevention or treatment is operating outside both the evidence base and UK supplement-marketing rules. [2]
Common online questions
Synthesised from the questions UK shoppers most often ask online about Saw Palmetto. Each answer is editorial and links to its evidence in the Sources list below.
Does saw palmetto actually shrink the prostate?
The best independent evidence is mixed-to-negative. The 2012 Cochrane review pooling 32 RCTs found no statistically significant benefit on the standard urinary symptom score (IPSS), peak flow, or nocturia versus placebo. Two large NIH-funded trials (STEP and CAMUS) tested the standard 320 mg/day dose and an escalated dose against placebo and found no meaningful improvement. Some trials of one specific preparation (Permixon®) report results broadly comparable to tamsulosin, but heterogeneity between extracts limits confident general claims. If you have urinary symptoms that bother you, see your GP — there are NHS pathways with treatments of better-defined effect. [5,1]
CO₂ extract vs ground-berry powder — does it matter?
Yes, materially. The lipidosterolic extracts used in the better trials are oils standardised to 85–95% total fatty acids and 0.2–0.4% sterols, prepared by supercritical CO₂ extraction or hexane/ethanol extraction and supplied as soft-gels. A 320 mg dose of one of those extracts is not the same as 320 mg of dried berry powder, which contains a small and unstudied lipid fraction. If your label does not state extract method and fatty-acid percentage, you do not know what you are taking.
Will saw palmetto interfere with PSA blood tests or my GP's assessment?
Published data is mixed; some studies show no PSA effect, others a small reduction at higher doses. To avoid confusing a screening result, tell your GP if you take saw palmetto before any PSA test or urology referral — this is the same conversation you should have about any supplement before tests.
Can I take saw palmetto with finasteride or tamsulosin?
Both finasteride and saw palmetto are reported to inhibit 5α-reductase in laboratory models, so combining them theoretically duplicates the same mechanism without adding clinical benefit. Tamsulosin works on a different pathway (alpha-1 adrenergic blockade). UK guidance does not endorse adding saw palmetto to a prescribed BPH regimen. Ask your prescribing pharmacist or GP before adding a supplement to any active prescription. [1]
Is saw palmetto safe long-term?
Trials up to 18 months have not flagged major safety signals at the standard 320 mg/day dose of standardised extract. Mild GI complaints (nausea, abdominal discomfort) are the most-reported side effect. Rare case reports of liver injury and reversible bleeding around surgery have been published; stop saw palmetto two weeks before any planned surgery and tell your anaesthetist. The absence of long independent trials limits confidence about multi-year use.
🔬 Camden’s evidence review
The research Camden reviewed, graded on its strength. This is our own appraisal — it sits beneath the official guidance above, never above it.
Lower urinary tract symptoms in benign prostatic hyperplasia (BPH)
MixedEvidencemixedThe most-cited Cochrane review (Tacklind 2012, CD001423) of 32 RCTs in ~5,500 men found no statistically significant difference between Saw Palmetto and placebo on the International Prostate Symptom Score (IPSS), nocturia, or peak urinary flow rate. Earlier reviews suggested modest benefit but were dominated by smaller trials with higher risk of bias. The two largest independent NIH-funded RCTs, STEP (Bent 2006, NEJM) and CAMUS (Barry 2011, JAMA), reported no meaningful benefit at standard or escalated doses. Some trials of the specific Permixon® preparation report effect sizes broadly comparable to tamsulosin, but methodological heterogeneity limits confident pooling. [5]
Androgenetic alopecia (male pattern hair loss)
LimitedEvidencelimitedA small number of trials have explored topical or oral saw palmetto in men with androgenetic alopecia. Effect sizes are smaller than for finasteride, comparison trials are short, and independent replication is thin. The Cochrane review of androgenetic alopecia interventions does not list saw palmetto among first-line options.
Prostate cancer prevention or treatment
InsufficientEvidenceinsufficientSaw palmetto is not a treatment for prostate cancer and is not part of NHS prevention guidance. Any urinary symptom that is new, persistent, or accompanied by blood requires medical assessment. [2]
Safety
Saw palmetto is generally well tolerated at 320 mg/day of standardised extract in trials up to 18 months. Mild digestive complaints are the most common side effect. Independent trials have not shown a clinically meaningful benefit on urinary symptoms over placebo, so do not delay seeing your GP about new or worsening symptoms.
Talk to your pharmacist or GP first if you:
- You take an anticoagulant (warfarin, apixaban, rivaroxaban, dabigatran, edoxaban) or antiplatelet (clopidogrel, prasugrel, ticagrelor) — case reports of bleeding events and pre-surgical bruising have been published.
- You are taking finasteride, dutasteride, tamsulosin, or another prescribed BPH medicine — duplicate-mechanism risk and unclear clinical interaction.
- You take hormonal therapy or have a hormone-sensitive condition.
- You have any planned surgery in the next 14 days — stop saw palmetto two weeks before and tell your anaesthetist.
- Your urinary symptoms are new, getting worse, painful, or accompanied by blood — these need GP assessment, not a supplement.
- You are due a PSA blood test or urology appointment — disclose all supplements to your clinician beforehand.
Common side effects: Mild gastrointestinal complaints (nausea, abdominal discomfort) in roughly 1–10% of users. Headache and dizziness reported less commonly. Rare case reports of liver injury and bleeding events.
Pregnancy and breastfeeding
Saw palmetto is not used in pregnancy. The product is marketed at men; the ingredient interacts theoretically with androgen pathways and has no safety data supporting use in pregnancy or breastfeeding. Avoid.
Insufficient safety data; avoid.
Talk to your GP, midwife, or pharmacist before starting any supplement during pregnancy or breastfeeding.
More clinical detail (for clinicians and informed readers)
Contraindications
- Known hypersensitivity to saw palmetto or any constituent of the supplement.
- Active liver disease — discuss with your GP first.
Drug interactions
- Anticoagulants and antiplatelets — case reports of increased bleeding; combination not contraindicated but flag to pharmacist.
- Finasteride / dutasteride — theoretical duplicate 5α-reductase inhibition; clinical interaction not characterised.
- Hormonal therapies — limited data; conservative practice is to disclose use to prescriber.
This is not an exhaustive list. Always tell your prescriber and pharmacist about every supplement you take.
Common side effects
- Mild gastrointestinal complaints — nausea, abdominal discomfort, diarrhoea (typically resolves with food or dose reduction).
- Headache, dizziness — uncommon but reported in trials.
Rare side effects
- Hepatotoxicity — case reports of cholestatic liver injury have been published; pattern is rare and reversible on stopping.
- Bleeding events — case reports of intra-operative haemorrhage and bruising; mechanism uncertain (possibly platelet effects).
- Allergic reactions — rare hypersensitivity reactions documented.
How to take it
- Typical supplemental range
- Trials of standardised lipidosterolic extracts have most commonly used 320 mg/day, taken as a single dose or split as 160 mg twice daily. Ground-berry preparations have not been studied at directly comparable doses.
- Timing
- No specific timing requirement. Soft-gels are generally taken with a meal containing some fat to support absorption of fat-soluble extracts.
How to spot quality
Look for
- Lipidosterolic extract clearly stated — supercritical CO₂ extraction is preferred; hexane/ethanol extraction is the historical alternative.
- Standardisation declared: total fatty acids 85–95% and free fatty acids ≥80% are the values used in published research-grade extracts.
- Dose stated as the extract weight (e.g. 320 mg), with the extraction method named on the label.
- Soft-gel format — supports stability and absorption of the lipid fraction.
- GMP-certified manufacture; ideally batch-level documentation available.
Red flags
- Label says only "saw palmetto powder" or "saw palmetto berries" with no extract method and no standardisation percentage.
- No fatty-acid percentage stated.
- Hard-shell capsule of dry powder marketed at the same dose as a soft-gel extract — these are not equivalent.
- Marketing implies "natural finasteride", testosterone modulation, prostate cancer prevention, or guaranteed hair regrowth — none are supported by UK-authorised evidence.
- Any wording implying medical management of BPH, prostate cancer, or male pattern hair loss.
Where Camden lands · gap declared
Camden Medicals does not stock a saw palmetto product and is not currently planning one. A Phase-2 purchase order was evaluated and retracted: the available supply was dry whole-berry powder, whereas the encyclopaedia look-for bar — and the published trials — require a standardised lipidosterolic extract (supercritical CO₂ or hexane, 85–95% total fatty acids). Dry whole-berry powder is not the material the evidence base studied. This entry is retained as a UK-anchored Verifera reference — including to set out, honestly, that the independent trial evidence (notably the Cochrane review, Tacklind 2012) has not shown a clinically meaningful benefit over placebo.
Commonly combined with
Other ingredients that share a biological pathway, cofactor relationship, or evidence-backed protocol with this one. Mechanisms below cite primary physiology — not folk pairing. Doses are literature ranges, not recommendations. Talk to your pharmacist or GP before changing your stack, especially if you take prescription medication.
Zinc
Limited evidenceMen's-health cluster — both feature in BPH / prostate-supportive supplementation framings.
Saw palmetto fatty-acid lipidosterolic extract modulates 5-α-reductase + androgen-receptor signalling; zinc modulates testosterone metabolism + 5-α-reductase. Mechanism complementary on androgen-axis.
Evidence: UK Article 13.1 zinc testosterone-maintenance claim authorised. [4]
Doses studied: 320 mg saw palmetto extract + 10-15 mg zinc daily.
Selenium
Limited evidenceMen's-health cluster — selenium supports normal spermatogenesis (UK Article 13.1) alongside saw palmetto BPH-symptom support.
Selenium is a cofactor for selenoprotein P + glutathione peroxidase in seminiferous epithelium. UK Article 13.1 spermatogenesis claim. Saw palmetto modulates 5-α-reductase. Mechanism complementary.
Evidence: UK Article 13.1 selenium claim authorised. [4]
Doses studied: 320 mg saw palmetto + 100-200 µg L-selenomethionine daily.
Found in Camden: Purifera™ Selenium 200µg L-Selenomethionine 120 Capsules